Resources Repository
-
Resource PortalWeb Portal, Teaching Resource 2024MIDAS
MIDAS is a collaborative network of research scientists who use computational, statistical and mathematical models …
MIDAS is a collaborative network of research scientists who use computational, statistical and mathematical models to understand infectious disease dynamics and thereby assist the nation to prepare for, detect and respond to infectious disease threats. Midas focuses on research topics such as: Dynamics of emergence and spread of pathogens; Identification and surveillance of infectious diseases; Effectiveness and consequences of intervention strategies; Host/pathogen interactions; Ecological, climatic, economic and evolutionary dimensions of infectious diseases; The roles of behavior and behavioral adaptation in…
Mathematical Models | Cost-Effectiveness Analysis | Risk Analysis | Health/Medicine | Global | Policy/Regulation | Health Systems | Infectious Diseases | Dynamic Transmission | Calibration/Validation | Dynamic Simulation | Technology Assessment | Climate/Environment | Science/Technology | Graduate | Doctoral | Professional | Critical Thinking/Analysis | Conceptual Mapping | Quantitative Literacy -
OrganizationWeb Portal 2024ISPOR
Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics …
Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) exists to advance the policy, science, and practice of pharmacoeconomics (health economics) and health outcomes research. ISPOR publishes Value in Health, which contains original research articles in the areas of economic evaluation, outcomes research, and conceptual, methodological, and health policy articles. Beyond health economics and outcomes research resources, tools of ISPOR include strategic initiatives, publications, and member…
Mathematical Models | Cost-Effectiveness Analysis | Health/Medicine | Global | Policy/Regulation | Health Systems | Child/Nutrition | Infectious Diseases | Preferences/Values | Priority Setting/Ethics | Costing Methods | Health Outcomes | Value of Information | Technology Assessment | Operations Research | Maternal/Reproductive Health | Chronic Disease/Risk | Business/Industry | Economics/Finance | Science/Technology -
Resource PortalWeb Portal, Teaching Resource 2024National Academies of Sciences, Engineering, and Medicine
The National Academies of Sciences, Engineering, and Medicine, founded in 1863, has a mission to provide …
The National Academies of Sciences, Engineering, and Medicine, founded in 1863, has a mission to provide nonpartisan, objective guidance for decision makers on policy challenges in the context of science, engineering, and medicine. NAS reports and convening activities have a wide range of impacts on policy and practice. They guide the development of federal laws and regulations, improve the effectiveness of government programs, shape the direction of research fields, and inform public knowledge and dialogue about…
Cost-Effectiveness Analysis | Risk Analysis | Health/Medicine | Global | Health Systems | Injuries/Accidents | Child/Nutrition | Infectious Diseases | Priority Setting/Ethics | Health Outcomes | Evidence Synthesis | Technology Assessment | Maternal/Reproductive Health | Chronic Disease/Risk | Social Determinants | Global Governance | Climate/Environment | Energy/Engineering | Education/Labor | Food/Agriculture | Military/Defense | Science/Technology | North America | High School | College | Graduate | Doctoral | Professional | Critical Thinking/Analysis | Decision Making/Leadership | Policy Translation -
ArticlePublication 2014Cost-Effectiveness of Female HPV Vaccination in 179 Countries: A PRIME Modelling Study
The authors present a simple generic model, Papillomavirus Rapid Interface for Modelling and Economics (PRIME), …
The authors present a simple generic model, Papillomavirus Rapid Interface for Modelling and Economics (PRIME), used to assess cost-effectiveness and health effects of vaccination of girls against HPV before sexual debut in terms of burden of cervical cancer and mortality. The PRIME models incidence according to proposed vaccine efficacy against HPV 16/18, vaccine coverage, cervical cancer incidence and mortality, and HPV type distribution. It assumes lifelong vaccine protection and no changes to other screening programs…
Mathematical Models | Cost-Effectiveness Analysis | Health/Medicine | Latin America & Caribbean | Global | Health Systems | Infectious Diseases | Health Outcomes | Calibration/Validation | Chronic Disease/Risk | Sub-Saharan Africa | Middle East & North Africa | Asia & Pacific -
Resource PackWeb Portal, Teaching Resource 2017Resource Pack: Valuing Vaccines and GAVI
This resource pack on valuing vaccines and GAVI was curated by the Center for Health …
This resource pack on valuing vaccines and GAVI was curated by the Center for Health Decision Science to showcase existing information and analyses to motivate students, educators and others to pursue new applications of decision science methods to the public health challenge of vaccine preventable illnesses.
Mathematical Models | Cost-Effectiveness Analysis | Health/Medicine | Global | Health Systems | Child/Nutrition | Infectious Diseases | Preferences/Values | Priority Setting/Ethics | Costing Methods | Dynamic Transmission | Calibration/Validation | Benefit-Cost Analysis | Global Governance | Economics/Finance | Government/Law | Science/Technology | Graduate | Doctoral | Professional | Critical Thinking/Analysis | Policy Translation | Quantitative Literacy -
ArticlePublication 2016Cost-Effectiveness of Routine Vaccination With a Live-Attenuated Dengue Vaccine: Model Comparison
Large Phase III trials across Asia and Latin America have demonstrated the efficacy of a recombinant, …
Large Phase III trials across Asia and Latin America have demonstrated the efficacy of a recombinant, live-attenuated dengue vaccine (Dengvaxia) over the first 25 months following vaccination. Subsequent data collected in the longer-term follow-up phase, however, have raised concerns about a potential increase in hospitalization risk of subsequent dengue infections, in particular among young, dengue-naïve vaccinees. This paper reports predictions from eight independent modelling groups on the long-term safety, public health impact, and cost-effectiveness of routine…
Mathematical Models | Cost-Effectiveness Analysis | Health/Medicine | Latin America & Caribbean | Health Systems | Child/Nutrition | Infectious Diseases | Dynamic Transmission | Global Governance | Climate/Environment | Economics/Finance | Asia & Pacific -
ReviewPublication 2003Public Health Policy and Cost-Effectiveness Analysis
This chapter presents an overview of the uses for cost-effectiveness analysis and disease-simulation modeling to …
This chapter presents an overview of the uses for cost-effectiveness analysis and disease-simulation modeling to rigorously evaluate alternatives to reduce mortality from cervical cancer. Scientific advances have provided opportunities over time to revisit strategies for cervical cancer prevention. How to invest health resources wisely, such that public health benefits are maximized-and opportunity costs are minimized-is a critical question in the setting of enhanced cytologic screening methods, human papillomavirus DNA testing, and vaccine development. Developing sound…
Mathematical Models | Cost-Effectiveness Analysis | Health/Medicine | Global | Policy/Regulation | Health Systems | Infectious Diseases | Chronic Disease/Risk -
ReportPublication 2017DCP3: Improving Health and Reducing Poverty
This report from the World Bank is the ninth and final volume of the Disease …
This report from the World Bank is the ninth and final volume of the Disease Control Priorities, Third Edition (DCP3) series. It provides an overview of the findings and methods explored in the first eight volumes, placing them within a framework that identifies an efficient pathway toward essential universal health coverage through the implementation of 21 essential packages that include health interventions and fiscal and intersectoral policies. The Disease Control Priorities Network (DCP) promotes and…
Cost-Effectiveness Analysis | Health/Medicine | Global | Policy/Regulation | Health Systems | Injuries/Accidents | Child/Nutrition | Infectious Diseases | Costing Methods | Health Outcomes | Evidence Synthesis | Benefit-Cost Analysis | Maternal/Reproductive Health | Chronic Disease/Risk | Mental Health | Social Determinants | Global Governance | Economics/Finance | Government/Law | Science/Technology -
Resource PortalWeb Portal, Teaching Resource 2021Disease Control Priorities (DCP3)
DCP3 includes a comprehensive review of the efficacy, effectiveness, and cost-effectiveness of priority health interventions …
DCP3 includes a comprehensive review of the efficacy, effectiveness, and cost-effectiveness of priority health interventions with the goal of influencing program design and resource allocation at global and country levels. DCP3 includes nine individual volumes, with the first eight structured around packages of conceptually related interventions, and the ninth providing an overview of main findings. Publicly available resources include journal articles and reports, both DCP3 and non-DCP3 related, as well as presentations, working papers, and book…
Cost-Effectiveness Analysis | Health/Medicine | Global | Policy/Regulation | Health Systems | Injuries/Accidents | Child/Nutrition | Infectious Diseases | Priority Setting/Ethics | Costing Methods | Evidence Synthesis | Maternal/Reproductive Health | Chronic Disease/Risk | Mental Health | Science/Technology | High School | College | Graduate | Doctoral | Professional | Critical Thinking/Analysis | Policy Translation